BEGIN:VCALENDAR
PRODID:-//planitpurple.northwestern.edu//iCalendar Event//EN
VERSION:2.0
CALSCALE:GREGORIAN
METHOD:PUBLISH
CLASS:PUBLIC
BEGIN:VTIMEZONE
TZID:America/Chicago
TZURL:http://tzurl.org/zoneinfo-outlook/America/Chicago
X-LIC-LOCATION:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:19700308T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:19701101T020000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
SEQUENCE:0
DTSTART;TZID=America/Chicago:20260430T100000
DTEND;TZID=America/Chicago:20260430T110000
DTSTAMP:20260414T162841Z
SUMMARY:BMG Seminar: George O'Toole\, PhD
UID:641313@northwestern.edu
TZID:America/Chicago
DESCRIPTION:The Department of Biochemistry & Molecular Genetics presents:  George O’Toole\, PhD  Elmer R. Pfefferkorn\, PhD\, Professor of Microbiology and Immunology  Editor in Chief\, Journal of Bacteriology  Dept. of Microbiology & Immunology  Title: To Build a Biofilm  Polymicrobial infections represent a significant challenge. For example\, despite significant successes developing new therapeutics to treat the underlying causes of cystic fibrosis (CF) and substantial efforts to target the microbes associated with airway damage\, infections associated with CF are still a significant cause of morbidity and mortality. A major cause of persistent\, drug-recalcitrant infections in persons with CF is their polymicrobial nature. The ability of polymicrobial communities to cause disease\, persist in vivo and withstand higher concentrations of antimicrobial agents is multifactorial and incompletely understood. Emerging evidence suggests that microbial community composition dramatically alters the ability of antimicrobial agents to eradicate infections - such interactions among microbes can result in decreased antimicrobial efficacy in vivo. Furthermore\, polymicrobial lung infections are associated with worse prognoses. I will discuss our recent efforts to leverage large clinical data sets from person with CF to develop a new in vitro\, polymicrobial community model\, and describe how we deploy this model to begin to understand mechanisms of microbial interactions and community function.  I also argue that our system can serve as novel antimicrobial screening platform and as “model” community to study microbial interactions more broadly  Host: Arthur Prindle\, PhD   Refreshments will be served.      
LOCATION:Simpson Querrey Biomedical Research Center\, SQBRC Auditorium\, 303 E. Superior Street\, Chicago\, IL 60611
TRANSP:OPAQUE
URL:https://planitpurple.northwestern.edu/event/641313
CREATED:20260401T050000Z
STATUS:CONFIRMED
LAST-MODIFIED:20260406T205212Z
PRIORITY:0
BEGIN:VALARM
TRIGGER:-PT10M
ACTION:DISPLAY
DESCRIPTION:Reminder
END:VALARM
END:VEVENT
END:VCALENDAR